Corcym provides advanced surgical heart valve solutions, addressing the growing global demand for durable and innovative cardiac surgery technologies
At a glance
Reference market: Cardiac surgery
Vertical: Medtech
FTEs: ~800
Acquisition year: 2021
Head office: Italy
Positive impact to society
Delivers life-saving solutions for structural heart disease, a leading global health challenge
Investment rationale
- Operates in a growing market driven by aging populations, greater healthcare access, innovation, and rising incidence of cardiac diseases
- Strategic play on the future of cardiac surgery - from open procedures to minimally invasive and robotic approaches - offering more durable alternatives vs. transcatheter solutions